Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, July 30 2015 8:16am ET - U.S. Markets open in 1 hour and 14 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Thursday, Jul 30, 2015
·Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015
Marketwire - 46 minutes ago
·Alkermes plc Reports Second Quarter 2015 Financial Results
Business Wire - 1 hour, 16 minutes ago
·Pharming Reports on Financial Results First Half Year 2015
PR Newswire - Thu 1:00 am ET
Wednesday, Jul 29, 2015
·RedHill Biopharma Reports Results for the Second Quarter of 2015
GlobeNewswire - Wed 6:05 am ET
Monday, Jul 27, 2015
·Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015
Marketwire - Mon Jul 27
·Morgan Stanley Lifts Target On Valeant From $235 To $284
- Mon Jul 27
·RedHill Biopharma Provides Update on RHB-106 Program Partnered with Salix Pharmaceuticals
GlobeNewswire - Mon Jul 27
Thursday, Jul 23, 2015
·Alkermes to Host Conference Call to Discuss Second Quarter 2015 Financial Results
Business Wire - Thu Jul 23
·Valeant Pharmaceuticals (VRX) Earnings Report: Q2 2015 Conference Call Transcript
at - Thu Jul 23
·Valeant 2Q results beat estimates sending stock up
AP - Thu Jul 23
·Valeant profit beats estimates as U.S. sales stay strong
Reuters - Thu Jul 23
·Valeant reports 2Q loss
AP - Thu Jul 23
·Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results
PR Newswire - Thu Jul 23
·Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results
CNW Group - Thu Jul 23
Wednesday, Jul 22, 2015
·Flamel Technologies Announces Results of 2015 Annual Meeting; Domestic U.S. Public Company Reporting Status to Begin in 2016
Marketwire - Wed Jul 22
Tuesday, Jul 21, 2015
·HAEi Global Access Program for RUCONEST® Now Live
PR Newswire - Tue Jul 21
Monday, Jul 20, 2015
·Delcath Receives Orphan Drug Designation From FDA For Melphalan To Treat Cholangiocarcinoma
PR Newswire - Mon Jul 20
·Flamel Technologies to Report Second Quarter of Fiscal Year 2015 Results
Marketwire - Mon Jul 20
·PetMed Express D/B/A 1-800-PetMeds Announces Its First Quarter Financial Results and Its $0.18 Per Share Quarterly Dividend
GlobeNewswire - Mon Jul 20
·Pharming Announces US$17 Million (€15.6 Million) Straight Debt Financing
PR Newswire - Mon Jul 20
More Latest News...
Sponsor Results
"New Crisis is Coming"
22-year Congressman speaks out and reveals #1 step to prepare.
USA TODAY® Special Offer
Get 1st 3 Months For Only $18! Subscribe Now, Sale Ends Soon.
Get NanoGreens® Direct
Nanogreens® direct from BioPharma ©Official Order Site Nanogreens 10®
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?